Brian Bettencourt
79Patents
10h-index
50Co-inventors
77Inventor score
Filing activity: Jan 25, 2011 → Jun 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9322018B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US9771591B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 16 | Active |
| US9783806B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US8507663B2 | Compositions and methods for inhibiting expression of CD274/PD-L1 gene | Emerging Cross-Sectional Technologies | 13 | Active |
| US10557139B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10337010B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10550390B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US9127274B2 | Serpinc1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US9249415B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US9574192B2 | Serapina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9133461B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 10 | Active |
| US9879261B2 | Serpina1 siRNAs: compositions of matter and methods of treatment | Physics | 9 | Active |
| US10238749B2 | Angiotensinogen (AGT) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US9944671B2 | Compositions and methods directed to treating liver fibrosis | Chemistry; Metallurgy | 7 | Active |
| US9701963B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10030244B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10465194B2 | Complement component iRNA compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US9175290B2 | Compositions and methods for inhibiting expression of TMPRSS6 gene | Chemistry; Metallurgy | 6 | Active |
| US9422562B2 | Compositions and methods for inhibiting expression of CD274/PD-L1 gene | Emerging Cross-Sectional Technologies | 5 | Active |
| US9850488B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US9376680B2 | Serpinc1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US9631193B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 5 | Active |
| US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10913950B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11079379B2 | Methods of treating transthyretin (TTR) mediated amyloidosis | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.